Westside Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-300
| Closed | -$6.5K | – | 908 |
|
|
2023
Q4 | $6.5K | Hold |
300
| – | – | ﹤0.01% | 662 |
|
|
2023
Q3 | $6.17K | Sell |
300
-400
| -57% | -$8.23K | ﹤0.01% | 661 |
|
|
2023
Q2 | $32.9K | Hold |
700
| – | – | 0.01% | 418 |
|
|
2023
Q1 | $29.4K | Hold |
700
| – | – | 0.01% | 441 |
|
|
2022
Q4 | $26 | Hold |
700
| – | – | ﹤0.01% | 503 |
|
|
2022
Q3 | $27 | Hold |
700
| – | – | ﹤0.01% | 476 |
|
|
2022
Q2 | $22 | Hold |
700
| – | – | ﹤0.01% | 501 |
|
|
2022
Q1 | $23 | Sell |
700
-1,950
| -74% | -$64 | ﹤0.01% | 502 |
|
|
2021
Q4 | $112 | Hold |
2,650
| – | – | ﹤0.01% | 343 |
|
|
2021
Q3 | $117 | Hold |
2,650
| – | – | ﹤0.01% | 331 |
|
|
2021
Q2 | $150 | Hold |
2,650
| – | – | ﹤0.01% | 308 |
|
|
2021
Q1 | $198 | Sell |
2,650
-75
| -3% | -$6 | ﹤0.01% | 291 |
|
|
2020
Q4 | $235 | Sell |
2,725
-1,050
| -28% | -$91 | ﹤0.01% | 246 |
|
|
2020
Q3 | $230 | Sell |
3,775
-500
| -12% | -$30 | ﹤0.01% | 253 |
|
|
2020
Q2 | $177 | Buy |
4,275
+300
| +8% | +$12 | ﹤0.01% | 243 |
|
|
2020
Q1 | $114 | Buy |
+3,975
| New | +$114 | ﹤0.01% | 268 |
|